UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
UC San Diego Health receives “LGBTQ+ Healthcare Equality Leader” designation by the Human Rights Campaign Foundation for policies and practices dedicated to the equitable treatment and inclusion of LGBTQ+ patients, visitors and employees.
A UC San Diego pilot study on parents of mass shooting victims finds that eight weeks of mindfulness training is effective in reducing trauma, depression, stress and grief caused by gun violence.
UC San Diego study finds new screening tool flags 95 percent of stage 1 pancreatic cancers.
UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.
UC San Diego study shows neuroendocrine cells in the lungs drive a developmental lung disease, and a similar brain-lung interaction may contribute to COVID-19 symptoms. The findings suggest neuropeptides may be a promising therapeutic target for conditions with excess lung fluid.
The U.S. Agency for International Development has funded a $38 million, five-year project led by UC San Diego researchers to better understand and promote health agency for individuals, communities and local organizations in low- and middle-income countries.
The Adult Congenital Heart Disease program at UC San Diego Health has received accreditation from the Adult Congenital Heart Association (ACHA) as a comprehensive care center, a first for San Diego.
UC San Diego Health is the first hospital system in San Diego County to employ high-intensity, focused ultrasound (HIFU) for minimally invasive prostate cancer treatment.
UC San Diego School of Medicine, Weill Cornell Medicine and Stanford Medicine have launched a three-year study to investigate new ways to treat or prevent major depression, accelerate effective treatments and develop predictive models to identify which treatments work best for individual patients.
UC San Diego Health has become the first organization recognized as a Certified Center of Excellence in Medication-Use Safety and Pharmacy Practice by the American Society of Health-System Pharmacists.
Researchers at University of California San Diego School of Medicine and in Japan have used an ancient fish to reel in new insights about human biology and, in particular, how and why a widely used medication works to abort pregnancies (in people, not fish).
UC San Diego researchers discover a specific antimicrobial skin cell and the role it plays in acne development, which could result in more targeted treatment options.
UC San Diego Health researchers surveyed and compared early- and late-stage breast and colorectal cancer diagnoses in patients in pre-pandemic 2019 and in 2020, the first full year of the COVID-19 pandemic, discovering fewer of the former and more of the latter as patients delayed care.
New heart arrhythmia mapping technology debuts at UC San Diego Health.
Researchers at UC San Diego School of Medicine have presented data that suggests a new HIV outbreak in Tijuana, Mexico, driven in part by “drug tourism” unabated by the closure of the international border due to the COVID-19 pandemic.
People at risk of developing alcohol use disorder show lower functional connectivity between brain regions involved in processing facial expressions. Future psychoeducation programs focused on improving social and emotional processing may help prevent alcohol use disorder.
An international team of scientists, led by UC San Diego researchers, has used atlases of the human brain informed by genetics to identify hundreds of genomic loci. The findings illuminate how genes impact the brain and diseases.
Researchers looked at gender differences relative to wisdom, using two different validated scales and found that, in general, women scored higher on compassion-related items and on self-reflection while men scored higher on cognitive-related items and on emotional regulation.
The National Football League is funding a novel clinical trial by UC San Diego researchers to assess whether cannabis or CBD provide any post-game pain relief caused by athletic injury. Trial participants will be professional rugby players.
Remote UC San Diego School of Medicine study finds brain function boosted by daily exercise in middle-aged and older adults.
Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution.
Novel trial measured simulated driving performance of persons after cannabis use, revealing sharply differentiated levels of ability and perception of skills.
Transcranial magnetic stimulation offers hope for antidepressant-resistant psychiatric disorders at UC San Diego Health.
National Institutes of Health establishes Microbiome and Metagenomics Center at UC San Diego, part of new effort to predict individual responses to food and inform personalized nutrition recommendations.
UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.
A pioneering mentorship program at UC San Diego Health Sciences improved faculty satisfaction, especially among underrepresented faculty. The program serves as a successful model for other universities and medical schools looking to improve faculty diversity and success.
Marking its 30th anniversary and her enduring interest and support, philanthropist Darlene Shiley has given a $10 million gift for the clinical space expansion of the Shiley Eye Institute at UC San Diego Health.
Computer simulations from UC San Diego School of Medicine reveal the action mechanism and substrate specificity of an important blood enzyme. These findings open the door for new therapeutics against cardiovascular disease, and further support a unifying theory of phospholipase function.
Researchers at UC San Diego School of Medicine pinpoint the regions of the brain and neural mechanisms responsible for normal or impaired development of a child’s response to baby talk and why infants with autism do not typically respond well.
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego discover that Botox injections may reduce anxiety.
A celebratory groundbreaking event marks the beginning of a comprehensive revitalization project of UC San Diego’s Hillcrest campus, which upon completion will feature state-of-the-art facilities, expanded patient care services and technologies and other community amenities to promote wellbeing.
A grant awarded to UC San Diego will allow researchers to continue working with law enforcement and health professionals to develop educational programs and interventions that reduce traffic-related injuries and deaths.
Nixon Foundation funds effort to study and treat macular dystrophy at Shiley Eye Institute. Currently, there are no effective treatments to slow or prevent genetic condition.
How two of UC San Diego Health’s record-breaking 81 heart transplant recipients in 2021 forged a unique bond of mutual support.
Pediatric ophthalmologist with Shiley Eye Institute at UC San Diego Health explains why infantile cataracts are more common — and problematic — than most people realize.
UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.
UC San Diego School of Medicine partners with The Michael J. Fox Foundation on a clinical study to identify biomarkers of Parkinson’s disease. The study seeks to recruit 4,000 participants by the end of 2023.
Researchers report that an abbreviated, seven-item scale can help determine with high validity a person’s level of wisdom, a potentially modifiable personality trait that has been shown to have a strong association to well-being.
Novel randomized controlled trial found that families with high consumption of avocados experienced reduced caloric intake and an overall healthier diet, without actually changing their diet.
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
Artificial intelligence-based technique reveals previously unknown cell components that may provide new clues to human development and disease.
UC San Diego researchers have produced a single-cell chromatin atlas for the human genome. Delineating chromatin regions in cells of different human tissue types would be a major step toward understanding the role of gene regulatory elements (non-coding DNA) in human health or disease.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
